Revium Rx (RVRC) Notes Payables (2024 - 2025)
Revium Rx (RVRC) reported Notes Payables of $575000.0 for Q4 2025, up 57400.0% on a YoY basis from N/an in Q4 2024, and up 57400.0% sequentially from $1000.0 in Q4 2024.
Revium Rx (RVRC) Notes Payables (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Notes Payables data on file, last reported at $575000.0 in Q4 2025.
- For the quarter ending Q4 2025, Notes Payables rose 57400.0% year-over-year to $575000.0; the trailing twelve-month figure through Dec 2025 stood at $575000.0 (up 57400.0% YoY), and the FY2025 full-year result was $575000.0, up 57400.0% from the prior year.
- Notes Payables rose to $575000.0 in Q4 2025, from $1000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $575000.0 in Q4 2025 to a low of $1000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 575,000.00 |
| Dec 31, 2024 | 1,000.00 |